MK0916 in Patients With Type 2 Diabetes and Metabolic Syndrome

This study has been completed.

Sponsored by:	Merck
Information provided by:	Merck
ClinicalTrials.gov Identifier:	NCT00543595

Purpose

This study will test the safety and effectiveness of MK0916 in patients with Type 2 Diabetes Mellitus and Metabolic Syndrome.

This is an early phase trial and some specific protocol information is in progress and not publicly available at this time. (Full information is available to trial participants).

Condition	Intervention	Phase
Diabetes Mellitus, Type 2 Metabolic Syndrome	Drug: MK0916	Phase II

MedlinePlus related topics: Diabetes

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study

Further study details as provided by Merck:

Study Start Date:	August 2004
Study Completion Date:	May 2005

Eligibility

Ages Eligible for Study:	18 Years to 65 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Have Type 2 Diabetes
18 to 65 years of age

Exclusion Criteria:

History of Type 1 Diabetes Mellitus
Have been treated with insulin in the past 8 weeks
On a weight loss program and have ongoing weight loss
Taking weight loss medication
Have had surgery requiring general anesthesia in the past 30 days or have a planned surgery
Have taken another investigational drug in the last 8 weeks
Have active liver disease
Have a history of major surgery involving gastric or intestinal bypass

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00543595

Sponsors and Collaborators

Merck

Investigators

Study Director:

Medical Monitor

Merck

More Information

Study ID Numbers:	2007_643
Study First Received:	October 5, 2007
Last Updated:	October 12, 2007
ClinicalTrials.gov Identifier:	NCT00543595
Health Authority:	United States: Food and Drug Administration

Study placed in the following topic categories:

Metabolic Diseases
Diabetes Mellitus, Type 2
Diabetes Mellitus
Endocrine System Diseases

Endocrinopathy
Metabolic disorder
Glucose Metabolism Disorders

Additional relevant MeSH terms:

Pathologic Processes
Disease
Syndrome

ClinicalTrials.gov processed this record on January 15, 2009